New finding important to heart health, also changed faculty member's entire research path

Medical scientist Howard Young's research has taken a dramatic, unexpected turn in the last few months, thanks to a serendipitous chain of events that could lead to a genetic test that can predict heart failure in certain people before it happens.

It started when members of his team, Delaine Ceholski and Cathy Trieber, discovered a new mutation in a protein called phospholamban, which they predicted would cause the heart to be less responsive to changes in the body and eventually lead to . One month after submitting their paper to the for review, their work was validated when – in completely separate research – the mutation was found in two in Brazil.

"We predicted it exactly," said Young, an associate professor in the Faculty of Medicine & Dentistry's Department of Biochemistry and researcher with the National Institute of Nanotechnology. "It's interesting, because as basic researchers you feel like you have to constantly defend your research and how relevant test-tube work is to patients... and then one day, to our surprise, we were right.

"I expected to be right, but not in the time frame that occurred. It happened quickly."

Shortly after that, Young was asked to speak at the Centennial Lectures, a speakers series offered by the faculty as a lead-up to the medical school's centennial year in 2013 to spotlight the translational work of its researchers.

Young was paired with cardiologist and researcher Justin Ezekowitz of the Department of Medicine. Each became interested in the work of the other, and now the two are pairing up to screen patients' blood samples for mutations in the phospholamban protein.

"If someone had asked me last September if we'd ever get into sequencing patients' genes and trying to discover mutants, I would say 'no, you're wrong,' " said Young. "But now we're very interested in starting large sequencing

studies to try and find more mutations." Through his research, Young thinks he has established good prediction models for heart disease. If his research group finds a mutation in phospholamban through blood screening, Young believes he can predict the severity of the mutation and whether or not it will be associated with disease.

"It will be truly personalized medicine," said Young. "If we know they [patients] have a mutation before disease, monitoring and early treatment could improve and extend the quality of life for these patients."

Young and researchers in his lab will look at blood samples from about 750 patients at the Mazankowski Alberta Heart Institute. Young expects to find at least two or three people with a mutation in phospholamban.

They'll also look for other mutations that have not been previously discovered. "There's a related protein to phospholamban in the skeletal muscle and the atria of the , so we're branching out and going to see if we can identify new mutations, because no have been identified in that ," he said.

add to favorites email to friend print save as pdf

Related Stories

Researchers link gene mutations to Ebstein's anomaly

Feb 16, 2011

Ebstein's anomaly is a rare congenital valvular heart disease. Now, in patients with this disease, researchers of the Academic Medical Center Amsterdam in the Netherlands, the University of Newcastle, UK and the Max Delbrück ...

Genetic mutation implicated in 'broken' heart

Feb 15, 2012

For decades, researchers have sought a genetic explanation for idiopathic dilated cardiomyopathy (DCM), a weakening and enlargement of the heart that puts an estimated 1.6 million Americans at risk of heart failure each year. ...

Recommended for you

Learning from scorpions to control impulses

46 minutes ago

Scorpions can teach us a lot about the benefits of prolonging nerve impulses, and we might now be better students thanks to a study published in The Journal of General Physiology. The results could pave t ...

Study reveals how Listeria breaches the placenta

46 minutes ago

A gut bacterium called Listeria (Listeria monocytogenes), which is often found in soft cheese, is known to present a risk to pregnant women. Listeria uses distinct tactics to breach the intestine and the pl ...

Brazil finds coffee protein with morphine effect

Jan 25, 2015

Brazilian scientists have discovered a protein in coffee that has effects similar to pain reliever morphine, researchers at the state University of Brasilia (UnB) and state-owned Brazilian Agricultural Research ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.